BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
This Quarter Return
-13.11%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$255M
AUM Growth
+$255M
(-31%)
Cap. Flow
-$93.2M
Cap. Flow
% of AUM
-36.59%
Top 10 Holdings %
Top 10 Hldgs %
62.02%
Holding
34
New
6
Increased
12
Reduced
–
Closed
16
Top Buys
| 1 |
Incyte
INCY
|
$16M |
| 2 |
Intuitive Surgical
ISRG
|
$13.8M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.9M |
| 4 |
Brookdale Senior Living
BKD
|
$12.9M |
| 5 |
Biogen
BIIB
|
$12.4M |
Top Sells
| 1 |
Cigna
CI
|
$20.1M |
| 2 |
AET
Aetna Inc
AET
|
$19.1M |
| 3 |
Humana
HUM
|
$19.1M |
| 4 |
HNT
HEALTH NET INC
HNT
|
$16.4M |
| 5 |
Viatris
VTRS
|
$16.3M |
Sector Composition
| 1 | Healthcare | 86.38% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Edwards Lifesciences
EW
$47.8B
| $21.4M | 8.41% | 150,684 +68,856 | +84% | +$9.79M |
|
2
Perrigo
PRGO
$3.27B
| $18.1M | 7.1% | 115,000 +30,000 | +35% | +$4.72M |
|
3
Cooper Companies
COO
$13.4B
| $17.9M | 7.02% | 120,000 +18,770 | +19% | +$2.79M |
|
|
4
Incyte
INCY
$16.5B
| $16M | 6.27% | +144,710 | New | +$16M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $14.7M | 5.76% | 139,164 +44,499 | +47% | +$4.69M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $14.4M | 5.65% | 138,138 +23,138 | +20% | +$2.41M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14.1M | 5.52% | 89,884 +20,294 | +29% | +$3.17M |
|
|
CPHD
8
DELISTED
Cepheid Inc
CPHD
| $14M | 5.48% | 308,909 +103,845 | +51% | +$4.69M |
|
|
9
Intuitive Surgical
ISRG
$170B
| $13.8M | 5.41% | +30,000 | New | +$13.8M |
|
|
NUVA
10
DELISTED
NuVasive, Inc.
NUVA
| $13.7M | 5.4% | 285,000 +135,000 | +90% | +$6.51M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $12.9M | 5.08% | +150,000 | New | +$12.9M |
|
|
12
Brookdale Senior Living
BKD
$1.83B
| $12.9M | 5.05% | +560,220 | New | +$12.9M |
|
13
Centene
CNC
$14.3B
| $12.8M | 5.04% | 236,504 +25,676 | +12% | +$1.39M |
|
|
14
Biogen
BIIB
$19.4B
| $12.4M | 4.87% | +42,500 | New | +$12.4M |
|
15
Nektar Therapeutics
NKTR
$568M
| $12.1M | 4.73% | 1,100,000 +175,000 | +19% | +$1.92M |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $11.9M | 4.66% | 565,000 +215,000 | +61% | +$4.52M |
|
|
QGENF
17
DELISTED
QIAGEN NV
QGENF
| $11M | 4.31% | 425,000 +60,590 | +17% | +$1.56M |
|
|
CERN
18
DELISTED
Cerner Corp
CERN
| $10.8M | 4.24% | +180,000 | New | +$10.8M |
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -300,000 | Closed | -$12.6M |
|
20
Alkermes
ALKS
$4.78B
| – | – | -187,500 | Closed | -$12.1M |
|
|
21
Cigna
CI
$80.3B
| – | – | -124,312 | Closed | -$20.1M |
|
|
22
Humana
HUM
$36.5B
| – | – | -100,000 | Closed | -$19.1M |
|
23
Smith & Nephew
SNN
$16.3B
| – | – | -275,000 | Closed | -$9.34M |
|
24
Teva Pharmaceuticals
TEVA
$21.1B
| – | – | -175,000 | Closed | -$10.3M |
|
|
25
Viatris
VTRS
$12.3B
| – | – | -240,000 | Closed | -$16.3M |
|